CareDx Raises FY24 Revenue Guidance From $320M - $328M To $327M - $331M, Est $325.969M

Benzinga · Nov 5 05:37

CareDx now expects full year 2024 non-GAAP gross margin to be approximately 69%, compared to the prior range of 67% to 68%.

CareDx now expects full year 2024 adjusted EBITDA gain to be in the range of $18 million to $22 million, compared to the prior guidance of an adjusted EBITDA gain of $9 million to $15 million.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

CareDx Raises FY24 Revenue Guidance From $320M - $328M To $327M - $331M, Est $325.969M

Risk Disclaimer